Walgreens Is Going Private Soon. Why Earnings Are Sending the Stock Higher. -- Barrons.com

Dow Jones
08 Apr

Mackenzie Tatananni

Walgreens stock rose on Tuesday as an earnings beat lifted shares of the pharmacy chain, which is set to go private sometime in the calendar fourth quarter.

Walgreens posted adjusted earnings of 63 cents a share for the quarter ended Feb. 28, topping analysts' calls for 53 cents, according to FactSet. A loss of $2.853 billion in the quarter was narrower than the $5.908 billion loss recorded a year ago.

Quarterly sales climbed to $38.588 billion, up from $37.052 billion in the previous year and above the $37.971 billion Wall Street anticipated. The strong fiscal-second-quarter print gave shares a boost on Tuesday, with Walgreens stock rising 1.5% to $10.88 as the S&P 500 gained 3.7%.

Last month, Walgreens confirmed that it had struck an agreement with private-equity firm Sycamore Partners to be taken private. The company consequently withdrew its fiscal 2025 guidance, citing the buyout deal.

After nearly a century as a public company, the beleaguered retailer will be taken off the market as it faces billions of dollars of debt as well as opioid liabilities. The deal is valued at $23.7 billion, and the cash portion represents $10 billion of that.

Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

April 08, 2025 10:23 ET (14:23 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10